High Content Screening

Fluofarma has developed a High Content Screening (HCS) technology that improves the level of understanding of compounds and their effects, from the earliest stage of the discovery process onwards.

Base of HCS

High Content Screening is a powerful automated cell biology method that enables the functional analysis of several molecular events simultaneously in living cells. Key parameters to identify, select and characterize innovative compounds are measured by automated 96-well plate flow cytometry.

High Content Screening Technology

Download Platform.pdf

Breaking news

  • Scientific Publication

    Fluofarma is glad to announce a new scientific publication in the Journal of Cell Science.

    Read more [+]

  • GDDI Forum 2009

    Fluofarma will be attending Global Discovery & Development Innovation Forum 2009, in London, from March 2nd to 3rd.

    Read more [+]

Career opportunities:
Fluofarma is searching for new talents, currently several positions are available:
- Research Associates
- Bioengineers
Read more [+]